- Full text PDF available (3)
- This year (0)
- Last five years (1)
Disclaimer While the advice and information in these guidelines is believed to be true and accurate at the time of going to press, neither the authors, the British Society for Haematology, the British Transplantation Society nor the publishers accept any legal responsibility for the content of these guidelines.
The Serious Hazards of Transfusion (SHOT) Adverse Incident Reporting Scheme (SHOT Annual Reports, 1996–2008) has consistently reported that 30–40% of 'wrong blood' event errors are due to errors originating in the hospital blood transfusion laboratory with a disproportionate number occurring outside 'core hours'. Evidence collated from two national surveys… (More)
The aim of this study was to determine the compliance rates for women being offered routine antenatal anti-D prophylaxis in two obstetric units in the UK. Haemolytic disease of the newborn (HDN) is a potentially serious condition that can result in substantial morbidity and sometimes death. Current guidelines recommend that 500 IU anti-D immunoglobulin G… (More)
The SHOT Adverse Incident Reporting Scheme has consistently reported an unacceptably high level of errors originating in the laboratory setting. In 2006 an initiative was launched in conjunction with the IBMS, SHOT, RCPath, BBTS, UK NEQAS, the NHSE NBTC and the equivalents in Scotland, Wales and Northern Ireland that led to the formation of the UK TLC. The… (More)